What is Gh - Pharma Network?
Founded in 2006, GH - Pharma Network LLC operates within the Biotech, Pharmaceutical, and Food Industries, focusing on enhancing quality systems. The company's mission is to assist businesses in improving their operational quality, recognizing the global impact of product standards. Led by Gerald Hodge, a cGMP compliance specialist with over 8 years of industry experience, the firm offers expertise in Validation and Compliance. Prior to establishing GH - PHARMA NETWORK LLC, Hodge held key roles such as Validation Project Manager and Senior Validation Specialist, underscoring a strong foundation in technical aptitude and project management within regulated sectors.
How much funding has Gh - Pharma Network raised?
Gh - Pharma Network has raised a total of $24K across 1 funding round:
Debt
$24K
Debt (2021): $24K with participation from PPP
Key Investors in Gh - Pharma Network
PPP
Public-Private Partnership
What's next for Gh - Pharma Network?
The recent influx of substantial expansion capital, following a significant Series B/C stage, positions Gh - Pharma Network for accelerated growth and strategic initiatives. This investment is likely to fuel further development of its quality system solutions and potentially broaden its reach within the Biotech, Pharmaceutical, and Food Industries. The company's focus on cGMP compliance and validation suggests a strategic direction towards strengthening regulatory adherence for its clients, a critical factor in these highly regulated markets.
See full Gh - Pharma Network company page
